Oppenheimer lowered shares of Opthea (NASDAQ:OPT – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, MarketBeat reports. A number of other ...

Community, resilience and a call to action came into focus tonight as the Jewish Federation of St. Louis unveiled findings ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Goldman Sachs (NYSE:GS) shares continued gains for seven straight sessions, as the stock closed 2.65% higher at $580.10 on ...

Yet another face has joined the cast of Christopher Nolan’s The Odyssey, the star-studded adaptation of the Greek epic by ...

Among the titles to look out for are Mamma Mia, Kicking & Screaming, Dreamgirls, Last Night in Soho, Moneyball, Taken, Age of ...

Were a man to find himself one of the last humans left standing on a ravaged earth, surely one of the first questions he must ...

John Leguizamo feels like Christopher Nolan is producing his upcoming take on The Odyssey like an indie film, independent of studio interference.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 7 undervalued stocks in the Capital Markets industry for Monday, March 24, 2025. Let’s take ...

Tucked away in a secluded Welsh valley lies the abandoned Rhydymwyn's MS Valley Factory, a chemical weapons facility that ...

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), with a price ...

Peaky Blinders creator Steven Knight has teased what to expect from the new movie spin-off, which stars Cillian Murphy in the wake of his first Oscar win for Oppenheimer. At such a critical moment in ...